1. Home
  2. VRNA vs IVT Comparison

VRNA vs IVT Comparison

Compare VRNA & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • IVT
  • Stock Information
  • Founded
  • VRNA 2005
  • IVT 2005
  • Country
  • VRNA United Kingdom
  • IVT United States
  • Employees
  • VRNA N/A
  • IVT N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • IVT Real Estate Investment Trusts
  • Sector
  • VRNA Health Care
  • IVT Real Estate
  • Exchange
  • VRNA Nasdaq
  • IVT Nasdaq
  • Market Cap
  • VRNA 2.2B
  • IVT 2.3B
  • IPO Year
  • VRNA 2017
  • IVT N/A
  • Fundamental
  • Price
  • VRNA $35.66
  • IVT $30.16
  • Analyst Decision
  • VRNA Strong Buy
  • IVT Buy
  • Analyst Count
  • VRNA 6
  • IVT 3
  • Target Price
  • VRNA $43.83
  • IVT $31.33
  • AVG Volume (30 Days)
  • VRNA 1.1M
  • IVT 412.8K
  • Earning Date
  • VRNA 11-04-2024
  • IVT 10-29-2024
  • Dividend Yield
  • VRNA N/A
  • IVT 3.00%
  • EPS Growth
  • VRNA N/A
  • IVT 189.28
  • EPS
  • VRNA N/A
  • IVT 0.10
  • Revenue
  • VRNA $5,624,000.00
  • IVT $294,559,000.00
  • Revenue This Year
  • VRNA N/A
  • IVT N/A
  • Revenue Next Year
  • VRNA $554.09
  • IVT $12.37
  • P/E Ratio
  • VRNA N/A
  • IVT $344.68
  • Revenue Growth
  • VRNA 1127.95
  • IVT 13.58
  • 52 Week Low
  • VRNA $11.39
  • IVT $23.53
  • 52 Week High
  • VRNA $40.13
  • IVT $31.37
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 51.76
  • IVT 53.69
  • Support Level
  • VRNA $36.49
  • IVT $30.08
  • Resistance Level
  • VRNA $40.13
  • IVT $31.37
  • Average True Range (ATR)
  • VRNA 2.01
  • IVT 0.66
  • MACD
  • VRNA -0.30
  • IVT -0.00
  • Stochastic Oscillator
  • VRNA 47.60
  • IVT 63.73

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About IVT InvenTrust Properties Corp.

InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.

Share on Social Networks: